FAMATTA AJAVON: Open Payments
NPI 1649098591 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,565 in 47 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,565
Food & beverage: $1,565
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $455 |
| AstraZeneca Pharmaceuticals LP | 6 | $315 |
| Exact Sciences Corporation | 4 | $179 |
| KYOWA KIRIN, INC. | 1 | $122 |
| GlaxoSmithKline, LLC. | 6 | $107 |
| Lilly USA, LLC | 4 | $98 |
| PFIZER INC. | 3 | $63 |
| Novo Nordisk Inc | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $34 |
Products named: REPATHA, The Cologuard Plus Collection Kit, AIRSUPRA, BREZTRI, OTEZLA, EVENITY, MOUNJARO, FARXIGA.
Industry payments across MD — which companies pay providers there.
